The Expect Miracles Foundation – Financial Services Against Cancer Thursday announced its 2012 Expect Miracles Awards, sponsored by American Century Investments. This will be the program’s third year. Entries are being accepted through March 5.
The awards recognize individuals and firms in the financial services industry that have supported and shown commitment to the fight against cancer. The winners will be honored at the 19th Annual Mutual Fund Awards on April 5, 2012 at the Mandarin Oriental Hotel in New York.
The four categories are:
Corporate Commitment Award, recognizing a firm that has demonstrated organizational commitment to the fight against cancer.
Company for a Cure Award, recognizing a firm for an innovative initiative or event in 2011 that helped to further cancer awareness and raise funds for cancer-related programs.
Miracle Maker Leadership Award, recognizing an individual at an executive or board level who has demonstrated longstanding personal leadership in cancer advocacy.
Inspiration Contributor Award, recognizing an individual whose personal efforts helped to ensure the success of a cancer-related project, event or fundraising initiative during the previous year.
Past award recipients include: James E. Stowers, Jr., American Century Investments; J.Robert Jones, Jr., Bluff Point Associates; Louise Santosuosso, John Hancock Financial Services; Bernard Garil, UBS; Maureen Leary-Jargo, MFS Investment Management; Eaton Vance; The Haas Group and Merrill Lynch Global Wealth Management.
“The Foundation is priviledged to continue its partnership with American Century Investments, together celebrating remarkable heroes in the industry and the noble causes and charities they support,” said Expect Miracles Foundation Executive Director Christina E. Thirkell.
“Once again, American Century Investments is honored to work with the Expect Miracles Foundation in recognizing the heroes in the financial community who are showing leadership in the global fight against cancer,” said American Century Senior Vice President Mark Killen. “Our sponsorship of this initiative is a natural fit for our company, given the fact that more than 40% of American Century Investments’ profits support research to unlock the mysteries of cancer and other gene-based diseases.”